Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980;10(Suppl 2):407S–410S. doi: 10.1111/j.1365-2125.1980.tb01831.x

Gastrointestinal toxicity of minor analgesics

J M Duggan
PMCID: PMC1430173  PMID: 7002193

Abstract

1 The evidence for the risk of gastric erosions from aspirin is fragmentary.

2 Occult gastric bleeding following aspirin is poorly studied and the skewed distribution is unexplained; platelet factors may be relevant.

3 Overt gastric bleeding may follow aspirin; the risk is probably about one episode per two million doses.

4 There is epidemiological, clinical, experimental and histopathological evidence for an association between chronic aspirin use and chronic gastric ulcer.

5 An alternative to the Davenport hypothesis is proposed to explain the gastric action of aspirin and the non-steroidal anti-inflammatory agents.

6 Paracetamol is probably bland in its gastric actions.

Full text

PDF
407S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BILLINGTON B. P. OBSERVATIONS FROM NEW SOUTH WALES ON THE CHANGING INCIDENCE OF GASTRIC ULCER IN AUSTRALIA. Gut. 1965 Apr;6:121–133. doi: 10.1136/gut.6.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett A., Stamford I. F., Unger W. G. Prostaglandin E2 and gastric acid secretion in man. J Physiol. 1973 Mar;229(2):349–360. doi: 10.1113/jphysiol.1973.sp010142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bugat R., Thompson M. R., Aures D., Grossman M. I. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology. 1976 Nov;71(5):754–759. [PubMed] [Google Scholar]
  4. Cameron A. J. Aspirin and gastric ulcer. Mayo Clin Proc. 1975 Oct;50(10):565–570. [PubMed] [Google Scholar]
  5. Cooper G. N., Jr, Meade R. C., Ellison E. H. Heidenhain pouch bleeding due to oral salicylates. Arch Surg. 1966 Jul;93(1):171–174. doi: 10.1001/archsurg.1966.01330010173021. [DOI] [PubMed] [Google Scholar]
  6. Dagradi A. E., Falkner R. E., Lee E. R. Multiple benign gastric ulcers. A clinical and gastroscopic study. Am J Gastroenterol. 1974 Jul;62(1):36–45. [PubMed] [Google Scholar]
  7. Davenport H. W. Salicylate damage to the gastric mucosal barrier. N Engl J Med. 1967 Jun 8;276(23):1307–1312. doi: 10.1056/NEJM196706082762308. [DOI] [PubMed] [Google Scholar]
  8. Duggan J. M. Aspirin ingestion and perforated peptic ulcer. Gut. 1972 Aug;13(8):631–633. doi: 10.1136/gut.13.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Duggan J. M. Progress report. Aspirin in chronic gastric ulcer: an Australian experience. Gut. 1976 May;17(5):378–384. doi: 10.1136/gut.17.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Duggan J. M. The analgesic syndrome. Aust N Z J Med. 1974 Aug;4(4):365–372. doi: 10.1111/j.1445-5994.1974.tb03206.x. [DOI] [PubMed] [Google Scholar]
  11. Floate D. A., Duggan J. M. Hour-glass stomach: an explanation. Med J Aust. 1976 Oct 30;2(18):674–676. doi: 10.5694/j.1326-5377.1976.tb130423.x. [DOI] [PubMed] [Google Scholar]
  12. Ivey R. J., Silvoso G. R., Krause W. J. Effect of paracetamol on gastric mucosa. Br Med J. 1978 Jun 17;1(6127):1586–1588. doi: 10.1136/bmj.1.6127.1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jick H., Porter J. Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet. 1978 Jul 8;2(8080):87–89. doi: 10.1016/s0140-6736(78)91396-x. [DOI] [PubMed] [Google Scholar]
  14. Jorgensen T. G. Drug consumption before perforation of peptic ulcer. Br J Surg. 1977 Apr;64(4):247–249. doi: 10.1002/bjs.1800640406. [DOI] [PubMed] [Google Scholar]
  15. LYNCH A., SHAW H., MILTON G. W. EFFECT OF ASPIRIN ON GASTRIC SECRETION. Gut. 1964 Jun;5:230–236. doi: 10.1136/gut.5.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lanza F., Royer G., Nelson R. An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc. 1975 Feb;21(3):103–105. doi: 10.1016/s0016-5107(75)73812-9. [DOI] [PubMed] [Google Scholar]
  17. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med. 1974 May 23;290(21):1158–1162. doi: 10.1056/NEJM197405232902102. [DOI] [PubMed] [Google Scholar]
  18. MUIR A., COSSAR I. A. Aspirin and gastric haemorrhage. Lancet. 1959 Mar 14;1(7072):539–541. doi: 10.1016/s0140-6736(59)92308-6. [DOI] [PubMed] [Google Scholar]
  19. MUIR A., COSSAR I. A. Aspirin and ulcer. Br Med J. 1955 Jul 2;2(4930):7–12. doi: 10.1136/bmj.2.4930.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. MacDonald W. C. Correlation of mucosal histology and aspirin intake in chronic gastric ulcer. Gastroenterology. 1973 Sep;65(3):381–389. [PubMed] [Google Scholar]
  21. Mills D. G., Borda I. T., Philp R. B., Eldridge C. Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clin Pharmacol Ther. 1974 Feb;15(2):187–192. [PubMed] [Google Scholar]
  22. O'Brien P., Silen W. Effect of bile salts and aspirin on the gastric mucosal blood flow. Gastroenterology. 1973 Feb;64(2):246–253. [PubMed] [Google Scholar]
  23. Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res. 1976;2:507–520. [PubMed] [Google Scholar]
  24. Salter R. H. Aspirin and gastrointestinal bleeding. Am J Dig Dis. 1968 Jan;13(1):38–58. doi: 10.1007/BF02239210. [DOI] [PubMed] [Google Scholar]
  25. St John D. J., Yeomans N. D., De Boer W. G. Chronic gastric ulcer induced by aspirin: an experimental model. Gastroenterology. 1973 Oct;65(4):634–641. [PubMed] [Google Scholar]
  26. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES